user avatar
Incyte
@Incyte
Incyte’s official Twitter. Ready to Solve On. See our Community Guidelines: bit.ly/2sV0H5W
Wilmington, DE
Joined October 2015
Posts
  • user avatar
    To all mothers, sisters, aunts, wives, grandmothers & daughters and all others affected by #breastcancer - we are continuously inspired by your strength & vow to help raise awareness. This #BCAM, visit @NBCF to learn more. #bcsm
  • user avatar
    At this year's #WVD2019Houston meeting, we had the opportunity to ask @leethomastv, founder of @vstrong_detroit, why and how he helps raise awareness for #vitiligo. Thanks for sharing your story to inspire others!
    00:00
  • user avatar
    September is #BloodCancerAwarenessMonth! We're proud to stand with the MPN community to make a meaningful difference for patients.
    GIF
  • user avatar
    This #NCSD2018, we honor cancer survivors & the caregivers by their side who continue to inspire our rigorous pursuit of science to create innovative medicines. #ASCO18
  • user avatar
    Cancer research is fundamental to our work at Incyte. This month, we recognize National Cancer Research Month and thank our world-class scientists for their commitment to finding solutions for the serious unmet medical needs of our patients. #NCRM22 #ResearchSavesLives
    00:00
    National Cancer Research Month
    From incyte.com
  • user avatar
    Founded in 2002, Incyte has dedicated nearly 20 years to creating innovative medicines in oncology and dermatology for patients. Looking ahead to 2022, we will continue our pursuit to Solve On.
  • user avatar
    We asked #vitiligo advocates to describe in one word what a new FDA-approved treatment for vitiligo means to them. Here's what they said.
    00:00
    Impact of FDA Approval
    From incyte.com
  • user avatar
    Jim Lee, M.D., Ph.D., Group Vice President, Inflammation & AutoImmunity explains how we are using our cross-functional knowledge of JAK inhibition in our #dermatology efforts to address the needs of people with #immune-mediated dermatologic conditions.
    00:00
    Our Growing Portfolio
    From incyte.com
  • user avatar
    Paula Swain, our Executive Vice President of Human Resources, shares her perspective on Incyte being named a Top 100 Most Loved Workplace of 2022 by @Newsweek for the second year in a row. At Incyte, #WeSolveOn and it’s all made possible by our employees.
    00:00
    We Solve On.
    From incyte.com
  • user avatar
    This #WorldBloodCancerDay, join us in raising awareness for people living with various blood cancers. We are proud to continue to support the blood cancer community through our research and development efforts. #WBCD
    00:00
    World Blood Cancer Day
    From incyte.com
  • user avatar
    Living Dappled arms those with #vitiligo with education & inspiration to help them throughout their journey. We were able to connect with founder & patient advocate @ErikaPage at #WVD2019Houston to learn more about her work with & for the community.
    00:00
  • user avatar
    Our targeted therapy approach begins by uncovering what drives cells to become cancerous. This understanding helps us inform the design of molecules that directly or indirectly affect irregularities in cancer cells.
    00:00
  • user avatar
    There are over 6K existing #rarediseases. We're pursuing research that will provide hope for patients worldwide #ShowYourRare #CareAboutRARE
    00:00
  • user avatar
    This #WorldCancerDay and every day, we are committed to finding solutions for patients living with cancer. Learn more about our work in oncology.